Regulations/Policies – Express Pharma

UK fines pharma companies $360 million for overcharging NHS

Slashed GST rates on COVID-related items: The stakeholder view

Recent patent reforms will bolster innovative pharma research in China: GlobalData

Avenue Therapeutics gets complete response letter from USFDA for IV Tramadol

Lupin gets warning letter from US FDA for Somerset facility

Perspective on WTO IPR Waiver negotiations

Government issues operational guidelines for pharma PLI scheme

Procurement norms for ministries of health and pharma, DRDO relaxed

Mankind Pharma seeks CDSCO approval for Phase 1 Clinical Trials of patented anti-diabetic molecule

LDCs support India, South Africa’s request to waive COVID vaccine-related IPR